DAVID LEE JOHNSON

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Barbara G. McClung, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DAVID LEE JOHNSON:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vera Therapeutics, Inc. Chief Operating Officer Class A Common Stock 48,306 $2,446,215 $50.64 04 Feb 2026 Direct
Caribou Biosciences, Inc. Director Option to purchase Common Stock 45,000 20 Feb 2026 Direct
Vera Therapeutics, Inc. Chief Operating Officer Stock Option (right to buy) 40,000 04 Feb 2026 Direct
Global Blood Therapeutics, Inc. Chief Commercial Officer Common Stock 0 $46.99 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Chief Commercial Officer Restricted Stock Units 0 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 0 05 Oct 2022 Direct

Insider Reports Filed by DAVID LEE JOHNSON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRBU Caribou Biosciences, Inc. 20 Feb 2026 1 $0 4 Director 20 Feb 2026, 17:27
VERA Vera Therapeutics, Inc. 04 Feb 2026 2 $0 4 Chief Operating Officer 06 Feb 2026, 20:00
CRBU Caribou Biosciences, Inc. 20 Feb 2025 1 $0 4 Director 21 Feb 2025, 20:14
VERA Vera Therapeutics, Inc. 18 Feb 2025 2 $0 4 Chief Operating Officer 20 Feb 2025, 16:05
VERA Vera Therapeutics, Inc. 01 Jul 2024 1 $0 4 Chief Operating Officer 03 Jul 2024, 16:05
VERA Vera Therapeutics, Inc. 01 Jul 2024 0 $0 3 Chief Operating Officer 03 Jul 2024, 16:04
CRBU Caribou Biosciences, Inc. 20 Feb 2024 1 $0 4 Director 22 Feb 2024, 17:01
CRBU Caribou Biosciences, Inc. 21 Feb 2023 1 $0 4 Director 23 Feb 2023, 15:46
/report/000089924322033150-johnson-david-lee-2022-10-05 Global Blood Therapeutics, Inc. 05 Oct 2022 13 $0 4 Chief Commercial Officer 06 Oct 2022, 16:15
/report/000089924322030479-johnson-david-lee-2022-09-01 Global Blood Therapeutics, Inc. 01 Sep 2022 6 -$134,059 4 Chief Commercial Officer 06 Sep 2022, 19:00
/report/000089924322027635-johnson-david-lee-2022-08-01 Global Blood Therapeutics, Inc. 01 Aug 2022 4 -$75,881 4 Chief Commercial Officer 03 Aug 2022, 18:01
CRBU Caribou Biosciences, Inc. 18 May 2022 1 $0 4 Director 18 May 2022, 20:38
CRBU Caribou Biosciences, Inc. 11 May 2022 0 $0 3 Director 12 May 2022, 18:01
/report/000089924322013880-johnson-david-lee-2022-04-01 Global Blood Therapeutics, Inc. 01 Apr 2022 3 -$54,332 4 Chief Commercial Officer 05 Apr 2022, 19:00
/report/000089924322009262-johnson-david-lee-2022-03-01 Global Blood Therapeutics, Inc. 01 Mar 2022 7 -$16,581 4 Chief Commercial Officer 03 Mar 2022, 20:12
/report/000089924322004634-johnson-david-lee-2022-02-01 Global Blood Therapeutics, Inc. 01 Feb 2022 4 -$75,055 4 Chief Commercial Officer 03 Feb 2022, 16:44
/report/000089924321039183-johnson-david-lee-2021-10-01 Global Blood Therapeutics, Inc. 01 Oct 2021 3 -$56,962 4 Chief Commercial Officer 05 Oct 2021, 16:05
/report/000089924321035223-johnson-david-lee-2021-09-01 Global Blood Therapeutics, Inc. 01 Sep 2021 4 -$20,292 4 Chief Commercial Officer 03 Sep 2021, 20:01
/report/000089924321037667-johnson-david-lee-2021-08-01-restatement Global Blood Therapeutics, Inc. 01 Aug 2021 4 -$64,007 4/A Chief Commercial Officer 24 Sep 2021, 19:00